Skip to content

Chest Computed Tomography (CT) Screening Study With Antibody Testing

Different Strategies Using Autoantibodies and/or CT in the Detection of Lung Cancer

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01203579
Enrollment
0
Registered
2010-09-16
Start date
2011-09-30
Completion date
2011-09-30
Last updated
2012-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Keywords

CDT-Lung,CT scan,lung cancer detection

Brief summary

The purpose of this study is to assess the value of EarlyCDT-Lung test and CT scan both in lung cancer detection and potential health economic outcomes.

Detailed description

EarlyCDT-Lung test and CT scan both for lung cancer detection and potential economic outcomes.

Interventions

None listed

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
50 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Persons 50-75 * Asymptomatic for lung cancer * Current or former (stopped smoking less than 10 years ago) cigarette smokers * History of cigarette smoking of at least 20 pack years * History of cigarette smoking with a family history of lung cancer which gives an individual a personal risk similar to a smoking history of 20 pk/years (i.e. 1% at 5 years). * Mentally competent individuals to sign an informed consent. * Healthy enough to undergo pulmonary resection or stereotactic body radiotherapy. * A fully informed signed consent form must have been obtained.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026